BETAGRIN Announces Revolutionary New Energy Solution To Lead The Future Of Green Technology
[Global, October 15, 2023] – Today, BETAGRIN, a leading global green technology company, officially announced…
Articles
Golidocitinib Capsules: A breakthrough In A New Generation Of JAK1 Inhibitors
Among the latest advances in the pharmaceutical field, Golidocitinib Capsules, a new generation of JAK1…
FDA Accelerates Approval Of TALVEY™ (Talquetamab-tgvs) For The Treatment Of Multiple Myeloma
On 9 August 2023, the US Food and Drug Administration (FDA) announced the accelerated approval…
Astellas Pharmaceuticals Group: Driven By Innovation
March 19, 2025 – Astellas Pharma Group (TSE: 4503) continues to demonstrate its innovative strength…
Aclidinium Bromide Drug: A Promising For COPD Treatment
In recent years, the pharmaceutical industry has witnessed significant advancements in the treatment of chronic…
Fulzerasib Tablets: A New Era In Targeted Cancer Therapy
In a major breakthrough for precision oncology, Fulzerasib tablets have emerged as a promising treatment…
Iclusig: A Breakthrough In The Treatment Of Drug-Resistant Leukemia
In a significant advancement in the fight against leukemia, Iclusig (ponatinib) continues to demonstrate its…
How to Use Aspaveli (Pegcetacoplan) Safely: A Complete Patient Handbook
Introduction Aspaveli (pegcetacoplan) is a C3 complement inhibitor used for the treatment of paroxysmal nocturnal…
Qalsody: A Milestone In The Treatment Of Acromegaly
April 2023 – The U.S. Food and Drug Administration (FDA) today approved Qalsody (tofersen) for…
New Hepatitis B Treatment Pradefovir Mesylate Approved In China, Bringing New Hope To Chronic Hepatitis B Patients
China’s National Drug Administration (NMPA) has officially approved the marketing application for the novel anti-hepatitis…